Importance of the terminal portion of tumor time-activity curve in determining tumor dosimetry in radioimmunotherapy [5]

R. L. Wahl, K. Zasadny, M. S. Kaminski, J. F. Eary

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Importance of the terminal portion of tumor time-activity curve in determining tumor dosimetry in radioimmunotherapy [5]'. Together they form a unique fingerprint.